Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Companies Refuse to Lower Meningitis Vaccine Prices
PANA Wire Service;


Sources at a World Health Organization (WHO) meningitis meeting in Burkina Faso say that pharmaceutical companies have rejected requests to lower the price of the tetravalent meningitis vaccine to $1 a dose for countries that frequently experience epidemics of the disease. The best offer was reportedly made by GlaxoSmithKline, at $2.75 a dose. Experts said that many nations where the disease is prevalent, especially those in Africa, cannot afford the vaccine. They also expressed concern that the vaccines currently being used in the African meningitis belt do not protect against the W135 strain, which they said could spread from Burkina Faso to other countries in the region.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.